Oncolytic Biotechnology

Oncolytic Biotechnology is the study of oncolytic virus, the virus that preferentially infects and kills cancer cells. As the infected cancer cells are destroyed by oncolysis, they release new infectious virus particles or virions to help destroy the remaining tumour. Oncolytic viruses are thought not only to cause direct destruction of the tumour cells, but also to stimulate host anti-tumour immune responses.

    Related Conference of Oncolytic Biotechnology

    August 22-23, 2019

    5th International Congress on Epigenetics & Chromatin

    Vienna, Austria
    August 30-31, 2019

    International Conference on Genetic Disorders

    Bangkok, Thailand
    September 13-14, 2019

    12th World Congress on Cell & Tissue Science

    Singapore
    October 21-22, 2019

    23rd European Biotechnology Congress

    Zurich, Switzerland
    November 26-27, 2019

    International Conference On Genomics and Molecular Biology

    Lisbon | Portugal
    November 26-27, 2019

    International Conference on Cell and Gene Therapy

    | Lisbon, Portugal
    February 24-25, 2020

    24th Global Congress on Biotechnology

    London, UK
    March 16-17, 2020 |

    12th World Congress and Expo on Cell & Stem Cell Research

    Chicago, Illinois, USA
    May 21-22, 2020

    24th European Biotechnology Congress

    London,UK

    Oncolytic Biotechnology Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in